Insulet has been a great trade. While the S&P 500 was flat, the stock price has climbed by 14.6% to $265.87 per share. This ...

Shares of Insulet Corp. PODD slipped 1.74% to $260.27 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.33% to 5,693.31 and ...

Insulet Corporation PODD has witnessed strong momentum in the past year. Shares of the company have risen 62.9% compared with 9.9% growth of the industry during the same time frame. The S&P 500 ...

Let’s dig into the relative performance of Insulet (NASDAQ:PODD) and its peers as we unravel the now-completed Q4 patient ...

Envestnet Portfolio Solutions Inc. increased its holdings in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 2.3% during ...

This was the stock's second consecutive day of gains.

A randomized study from Insulet of adults and children with Type 1 diabetes found that moving from multiple daily injections ...

Just shy of two years after a C-suite reorganization at Insulet, Mark Field has left his position as the inaugural chief ...

Insulet shows bullish trends with strong growth, favorable Wall Street ratings, and a 3.2:1 reward-risk ratio. Read more on ...

Insulet (Nasdaq:PODD) announced today that it made its Omnipod 5 automated insulin delivery system available in several new ...

Insulet Corporation PODD has witnessed strong momentum in the past year. Shares of the company have risen 62.9% compared with 9.9% growth of the industry during the same time frame. The S&P 500 ...